Log in to save to my catalogue

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen rece...

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen rece...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10067156

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study

About this item

Full title

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study

Publisher

England: Springer

Journal title

Cardio-Oncology, 2023-04, Vol.9 (1), p.18-18, Article 18

Language

English

Formats

Publication information

Publisher

England: Springer

More information

Scope and Contents

Contents

Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and cardiovascular death occur in 10-15% of patients treated with CAR-T. This study aims to investigate the changes in cardia...

Alternative Titles

Full title

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10067156

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10067156

Other Identifiers

ISSN

2057-3804

E-ISSN

2057-3804

DOI

10.1186/s40959-023-00170-5

How to access this item